SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data
16 references·3 citing·35 second hop
Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data (1999)Sample size and power issues in estimatin…Clinical decision analysis (2005)Clinical decision analysisNet Health Benefits (1998)Net Health BenefitsHealth care contingent valuation studies: a review and classification of the literature (1998)Health care contingent valuat…Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation (1997)Pulling cost-effectiveness an…When Do the "Dollars" Make Sense? (1996)When Do the "Dollars" Make Se…Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations for reporting…Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations for Reporting…ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL (1996)ESTIMATING CONFIDENCE INTERVA…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis (1994)Uncertainty in the economic e…In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care (1994)In Search of Power and Signif…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Costs, effects and C/E‐ratios…How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)How attractive does a new tec…Methods for the economic evaluation of health care programmes (1987)Methods for the economic eval…Use and Misuse of the Term “Cost Effective” in Medicine (1986)Use and Misuse of the Term “C…Clinical Decision Analysis (1980)Clinical Decision AnalysisCost-effectiveness analysis for multinational clinical trials (2005)Cost-effectiveness analysis f…Incremental net benefit in randomized clinical trials with quality‐adjusted survival (2003)Incremental net benefit in ra…Incremental cost-effectiveness ratio and incremental net-health benefit: two sides of the same coin (2001)Incremental cost-effectivenes…Alternative to Mental Hospital Treatment (1980)A methodological framework for assessing health indices (1985)Measurement of health state utilities for economic appraisal (1986)The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument (1993)A study of the quality of life and cost-utility of renal transplantation (1996)A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial (2012)A Guide to Simulation (1983)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Intransitivity of preferences. (1969)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Increasing risk II: Its economic consequences (1971)The Analytics of Uncertainty and Information (1992)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Utility approach to measuring health-related quality of life (1987)Utilities and Quality-Adjusted Life Years (1989)Non‐formal learning and tacit knowledge in professional work (2000)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)The Estimation of a Preference-Based Measure of Health From the SF-12 (2004)Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report (2005)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1987Methods for the economic evaluation of health care programmes4,318 cited
  • 2005Clinical decision analysis1,591 cited
  • 1992How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1,581 cited
  • 1980Clinical Decision Analysis1,415 cited
  • 1996Recommendations for Reporting Cost-effectiveness Analyses1,274 cited
  • 1998Net Health Benefits1,104 cited
  • 1996Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine1,037 cited
  • 1994Costs, effects and C/E‐ratios alongside a clinical trial963 cited
  • 1997Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation883 cited
  • 1994Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis521 cited
  • 1998Health care contingent valuation studies: a review and classification of the literature474 cited
  • 1986Use and Misuse of the Term “Cost Effective” in Medicine417 cited
  • 1994In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care404 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 1996ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL313 cited
  • 1996When Do the "Dollars" Make Sense?294 cited
  • Cited by

    • 2005Cost-effectiveness analysis for multinational clinical trials53 cited
    • 2001Incremental cost-effectiveness ratio and incremental net-health benefit: two sides of the same coin52 cited
    • 2003Incremental net benefit in randomized clinical trials with quality‐adjusted survival51 cited